Research ArticleClinical Studies

Effects of the Antiestrogens Tamoxifen and Raloxifene on the Estrogen Receptor Transactivation Machinery

MICHAEL GLAESER, DIETER NIEDERACHER, SIRUS DJAHANSOUZI, BETTINA HANSTEIN, RALF DITTRICH, MATTHIAS W. BECKMANN, PETER A. FASCHING and SVEN ACKERMANN
Anticancer Research January 2006, 26 (1B) 735-744;

Article Information

vol. 26 no. 1B 735-744
PMID 
16739346
Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received September 14, 2005
  • Revision received November 1, 2005
  • Accepted December 6, 2005
  • Published online January 1, 2006.
Copyright & Usage 
Copyright© 2006 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. MICHAEL GLAESER1,
  2. DIETER NIEDERACHER1,
  3. SIRUS DJAHANSOUZI1,
  4. BETTINA HANSTEIN1,
  5. RALF DITTRICH2,
  6. MATTHIAS W. BECKMANN2,
  7. PETER A. FASCHING2 and
  8. SVEN ACKERMANN2
  1. 1Department of Gynecology and Obstetrics, Heinrich-Heine-University, Duesseldorf
  2. 2Department of Gynecology and Obstetrics, University Hospital Erlangen, Erlangen, Germany
  1. Correspondence to: Dr. R. Dittrich, Department of Gynecology and Obstetrics, University Hospital Erlangen, Universitätsstraße 21-23, 91054 Erlangen, Germany. Fax: 0049-9131-853-3552, e-mail: ralf.dittrich{at}gyn.imed.uni-erlangen.de

Statistics from Altmetric.com

Cited By...

Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
Effects of the Antiestrogens Tamoxifen and Raloxifene on the Estrogen Receptor Transactivation Machinery
MICHAEL GLAESER, DIETER NIEDERACHER, SIRUS DJAHANSOUZI, BETTINA HANSTEIN, RALF DITTRICH, MATTHIAS W. BECKMANN, PETER A. FASCHING, SVEN ACKERMANN
Anticancer Research Jan 2006, 26 (1B) 735-744;
Twitter logo Facebook logo Mendeley logo

Jump to section